Wilkinson et al.. “Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C” Biochem J. (1993) 294 pp. 335-337. |
Hidehiro Ishii et al. “Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor” Science 1996 272 (5262) pp. 728-731. |
D. Koya et al. “Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats” Journal of Clinical Investigation (Jul. 1, 1997) 100 (1) pp. 115-126. |
M.F. McCarty “A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors.” Medical Hypotheses, (Feb. 1998) 50 (2) pp. 155-165. |
E.N. Wardle “How does hyperglycaemia predispose to diabetic nephropathy?” QJM, (Dec. 1996) 89 (12) pp. 943-951. |
H. Ishii et al. “Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus” Journal of Molecular Medicine, (Jan. 1998) 76 (1) pp. 21-31. |